FISPB
ASND icon

Fideuram - Intesa Sanpaolo Private Banking’s Ascendis Pharma A/S ASND Stock Holding History

Fideuram - Intesa Sanpaolo Private Banking’s Portfolio ASND Stock Details ASND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.78M Sell
10,405
-238
-2% -$55.6K 0.08% 198
2026
Q1 		$2.43M Sell
10,643
-223
-2% -$50K 0.09% 213
2025
Q4 		$2.32M Buy
+10,866
New +$2.24M 0.08% 202

Other funds holding ASND

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Fideuram - Intesa Sanpaolo Private Banking's ASND Position: Q2 2026 in Review

Fideuram - Intesa Sanpaolo Private Banking reduced its Ascendis Pharma A/S (ASND) stake by 2.2% in Q2 2026, selling an estimated $55.6K and leaving 10,405 shares worth $2.78M. The position accounts for 0.08% of the portfolio, ranked #198.

Fideuram - Intesa Sanpaolo Private Banking first reported a position in ASND in Q4 2025 and has held it in 3 quarters since. 311 funds tracked by Wall St. Rank hold ASND as of Q2 2026.

  • Fideuram - Intesa Sanpaolo Private Banking held 10,405 shares of Ascendis Pharma A/S worth $2.78M as of Q2 2026.
  • Fideuram - Intesa Sanpaolo Private Banking sold 238 Ascendis Pharma A/S shares in Q2 2026, an estimated $55.6K.
  • Ascendis Pharma A/S made up 0.08% of Fideuram - Intesa Sanpaolo Private Banking's portfolio in Q2 2026, its #198 holding.
  • Fideuram - Intesa Sanpaolo Private Banking first reported a position in Ascendis Pharma A/S in Q4 2025 and has held it in 3 quarters since.
  • 311 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q2 2026.

Based on Fideuram - Intesa Sanpaolo Private Banking's 13F filing for Q2 2026, filed 23 Jul 2026.